- In January 2025, Abbott Laboratories announced the launch of ProGlide 2.0, an enhanced version of their popular Vascular Closure Device (VCD). It incorporates novel hemostatic seal technology, offering more precise control and faster sealing of arterial puncture sites. This innovation helps reduce recovery time and improves overall patient outcomes
- In October 2023, Terumo Corporation announced that its Angio-Seal VIP and Femoseal Vascular Closure Devices received certification under the new European Medical Device Regulation (EU MDR). The first CE-marked units of Femoseal reached the market in June 2023, and Angio-Seal VIP is expected in November 2023. This certification marks a significant milestone in improving femoral arterial hemostasis after percutaneous catheterization
